Trial intelligence / Profile preview

Phase IIIa crossover study of fospropofol disodium versus propofol in healthy volunteers

ChiCTR1800016329Phase 3Completed

Sponsor
West China Hospital of Sichuan University
Start
Dec 2017
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of fospropofol disodium and propofol (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Pharmacokinetic parameters, Bispectral index and 7 more. Started Dec 2017; status: completed.

02

Drugs

fospropofol disodiumpropofol

Beyond the preview

Go deeper on ChiCTR1800016329.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016329.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call